Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy

OBJECTIVE: To investigate feasibility, safety, and tolerability of long‐term (48 weeks) add‐on treatment with triheptanoin (UX007), the triglyceride of heptanoate, in adults with drug‐resistant epilepsy. METHODS: This extension study was offered to adult participants with drug‐resistant epilepsy who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epilepsia Open
Main Authors: Borges, Karin, Kaul, Neha, Germaine, Jack, Carrasco‐Pozo, Catalina, Kwan, Patrick, O’Brien, Terence J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Full‐length Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278596/
https://ncbi.nlm.nih.gov/pubmed/32524048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/epi4.12391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados